✦ LIBER ✦

Negative symptoms and psychosocial functioning in schizophrenia: Neglected but important targets for treatment

✍ Scribed by R. Hunter; S. Barry

Book ID: 118440185
Publisher: Elsevier Science
Year: 2012
Tongue: French
Weight: 465 KB
Volume: 27
Category: Article
ISSN: 0924-9338
DOI: 10.1016/j.eurpsy.2011.02.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.a.009 Negative symptoms: neglected b

P.3.a.009 Negative symptoms: neglected but important targets for treatment

✍ R. Hunter; S. Barry 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB

382 – Negative symptoms and verbal memor

382 – Negative symptoms and verbal memory as predictors of psychosocial functioning in young patients with schizophrenia

✍ O. Puig; R. Penadés; S. Andrés; I. Baeza; E. De La Serna; L. Lázaro; J. Castro-F 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Does negative symptom change relate to n

Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments

✍ Morris D. Bell; Aaron L. Mishara 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Paliperidone extended-release for schizo

Paliperidone extended-release for schizophrenia: Effects on symptoms and functioning in acutely ill patients with negative symptoms

✍ C.M. Canuso; C.A. Bossie; I. Turkoz; L. Alphs 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Inflammatory processes in schizophrenia:

Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

✍ Urs Meyer; Markus J. Schwarz; Norbert Müller 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 656 KB

Quetiapine versus olanzapine for the tre

Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia

✍ Pinkhas Sirota; Irit Pannet; Ady Koren; Eleonora Tchernichovsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych